
    
      The primary objective of this study is to evaluate the safety, tolerability, and
      pharmacokinetics of BMS-984923 in healthy participants. A secondary objective of this study
      is to conduct a receptor occupancy sub-study aimed at determining drug receptor occupancy at
      each dose using [18F]FPEB Positron Emission Tomography.
    
  